Literature DB >> 32065026

Estimating Social Variation in the Health Effects of Changes in Health Care Expenditure.

James Love-Koh1, Richard Cookson1, Karl Claxton1,2, Susan Griffin1.   

Abstract

Background. A common aim of health expenditure is to reduce unfair inequalities in health. Although previous research has attempted to estimate the total health effects of changes in health expenditure, little is known about how changes affect different groups in the population. Methods. We propose a general framework for disaggregating the total health effects of changes in health expenditure by social groups. This can be performed indirectly when the estimate of the total health effect has first been disaggregated by a secondary factor (e.g., disease area) that can be linked to social characteristics. This is illustrated with an application to the English National Health Service. Evidence on the health effects of expenditure across 23 disease areas is combined with data on the distribution of disease-specific hospital utilization by age, sex, and area-level deprivation. Results. We find that the health effects from NHS expenditure changes are produced largely through disease areas in which individuals from more deprived areas account for a large share of health care utilization, namely, respiratory and neurologic disease and mental health. We estimate that 26% of the total health effect from a change in expenditure would accrue to the fifth of the population living in the most deprived areas, compared with 14% to the fifth living in the least deprived areas. Conclusions. Our approach can be useful for evaluating the health inequality impacts of changing health budgets or funding alternative health programs. However, it requires robust estimates of how health expenditure affects health outcomes. Our example analysis also relied on strong assumptions about the relationship between health care utilization and health effects across population groups.

Entities:  

Keywords:  distributional cost-effectiveness analysis; health equity; health inequality; health opportunity cost

Mesh:

Year:  2020        PMID: 32065026      PMCID: PMC7430104          DOI: 10.1177/0272989X20904360

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  27 in total

1.  Health care spending as determinants of health outcomes.

Authors:  P Y Crémieux; P Ouellette; C Pilon
Journal:  Health Econ       Date:  1999-11       Impact factor: 3.046

Review 2.  Measures of health inequalities: part 2.

Authors:  Enrique Regidor
Journal:  J Epidemiol Community Health       Date:  2004-11       Impact factor: 3.710

Review 3.  The NICE cost-effectiveness threshold: what it is and what that means.

Authors:  Christopher McCabe; Karl Claxton; Anthony J Culyer
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 4.  Valuing health States for use in cost-effectiveness analysis.

Authors:  John Brazier
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

5.  Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.

Authors:  Karl Claxton; Steve Martin; Marta Soares; Nigel Rice; Eldon Spackman; Sebastian Hinde; Nancy Devlin; Peter C Smith; Mark Sculpher
Journal:  Health Technol Assess       Date:  2015-02       Impact factor: 4.014

6.  Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients?

Authors:  Karl Claxton; Mark Sculpher; Stephen Palmer; Anthony J Culyer
Journal:  Health Econ       Date:  2015-01       Impact factor: 3.046

7.  Distributional Cost-Effectiveness Analysis: A Tutorial.

Authors:  Miqdad Asaria; Susan Griffin; Richard Cookson
Journal:  Med Decis Making       Date:  2015-04-23       Impact factor: 2.583

8.  How a universal health system reduces inequalities: lessons from England.

Authors:  Miqdad Asaria; Shehzad Ali; Tim Doran; Brian Ferguson; Robert Fleetcroft; Maria Goddard; Peter Goldblatt; Mauro Laudicella; Rosalind Raine; Richard Cookson
Journal:  J Epidemiol Community Health       Date:  2016-01-19       Impact factor: 3.710

9.  Using Cost-Effectiveness Analysis to Address Health Equity Concerns.

Authors:  Richard Cookson; Andrew J Mirelman; Susan Griffin; Miqdad Asaria; Bryony Dawkins; Ole Frithjof Norheim; Stéphane Verguet; Anthony J Culyer
Journal:  Value Health       Date:  2017-02       Impact factor: 5.725

10.  Health Opportunity Costs: Assessing the Implications of Uncertainty Using Elicitation Methods with Experts.

Authors:  Marta O Soares; Mark J Sculpher; Karl Claxton
Journal:  Med Decis Making       Date:  2020-05-22       Impact factor: 2.583

View more
  5 in total

1.  Spatial and Temporal Differences in the Health Expenditure Efficiency of China: Reflections Based on the Background of the COVID-19 Pandemic.

Authors:  Yi Shi; Yufeng Xie; Huangxin Chen; Wenjie Zou
Journal:  Front Public Health       Date:  2022-04-14

2.  Impact of Socioeconomic Differences on Distributional Cost-effectiveness Analysis.

Authors:  Fan Yang; Colin Angus; Ana Duarte; Duncan Gillespie; Simon Walker; Susan Griffin
Journal:  Med Decis Making       Date:  2020-07-01       Impact factor: 2.583

3.  Innovations in cost-effectiveness analysis that advance equity can expand its use in health policy.

Authors:  Anton L V Avanceña; Lisa A Prosser
Journal:  BMJ Glob Health       Date:  2022-02

4.  Uncertainty Analysis in Intervention Impact on Health Inequality for Resource Allocation Decisions.

Authors:  Fan Yang; Ana Duarte; Simon Walker; Susan Griffin
Journal:  Med Decis Making       Date:  2021-06-08       Impact factor: 2.583

Review 5.  Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations.

Authors:  Matthew Franklin; James Lomas; Gerry Richardson
Journal:  Pharmacoeconomics       Date:  2020-07       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.